Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
497.20    -2.20 (-0.44%)
Bid:
495.80
Ask:
496.60
Spread: 0.80 (0.161%)
Market Cap: £1.35b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

CONTRACT AWARDS

20 Dec 2012 07:00

RNS Number : 9754T
Chemring Group PLC
20 December 2012
 



FOR IMMEDIATE RELEASE 20 December 2012

 

 

CHEMRING GROUP PLC

 NIITEK AWARDED $32 MILLION ADDITIONAL HMDS IDIQ DELIVERY ORDERS

 

Chemring Group PLC ("Chemring") is pleased to announce that its US subsidiary, Non-Intrusive Inspection Technology, Inc. ("NIITEK"), has been awarded two additional delivery orders totaling $32 million to provide spares for both the US Army and US Marine Corps. These delivery orders are issued as part of the multi-year Husky Mounted Detection System ("HMDS") Ground Penetrating Radar ("GPR") Indefinite-Delivery/Indefinite-Quantity ("IDIQ") contract that was awarded on 30 April 2012. This contract not only provides the US Army with the ability to procure spares and replacement systems to replenish theatre sustainment stock, but also provides the ability to serve future system requirements for the US Marine Corps and potential Foreign Military Sales. The potential value of the IDIQ contract is $579 million, with performance into 2013.

Mark Papworth, Chief Executive of Chemring, commented:

"We are delighted that these additional delivery orders enable us to continue our vital support to the US Army and US Marine Corps with NIITEK's HMDS products. Since the inception of the HMDS over four years ago, our commitment remains to provide the best explosives and mine detection capability to US and coalition forces currently in combat, as well as looking ahead to support them as they stand ready to conduct operations around the world."

-ENDS-

 

Chemring Group PLC

Rupert Pittman Director of Communications and Investor Relations

01489 881 880 / rupertp@chemring.co.uk

 

MHP Communications

Andrew Jaques / James White

0203 128 8100

 

Notes to Editors:

Chemring is a market leading manufacturing business supplying high technology electronics and energetic products to over eighty countries around the world. Chemring has a diverse portfolio of products that predominantly protect military people and platforms, providing insurance against a constantly changing threat. These range from countermeasures to protect aircraft, to ground penetrating radar to protect troops and vehicles from improvised explosive devices. NIITEK, a Chemring company since 2008, is the world leader in the design, development and production of Advanced Ground Penetrating Radar ("GPR") systems. NIITEK's Advanced GPR systems are at the leading edge of mine detection technology with over two hundred systems successfully being used by US and Coalition forces in Afghanistan.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTFFLEFUFESEIE
Date   Source Headline
3rd Apr 20253:20 pmRNSHolding(s) in Company - Replacement
3rd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSContract Award
1st Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20252:57 pmRNSHolding(s) in Company
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20251:46 pmRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20257:01 amRNSTotal Voting Rights
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20254:12 pmRNSHolding(s) in Company
27th Feb 20252:43 pmRNSDirector/PDMR Shareholdings
27th Feb 20258:00 amRNSHolding(s) in Company
27th Feb 20257:00 amRNSTransaction in Own Shares
26th Feb 20251:29 pmRNSResult of AGM
26th Feb 20257:00 amRNSAGM Update
25th Feb 20253:50 pmRNSHolding(s) in Company
21st Feb 20252:54 pmRNSHolding(s) in Company
3rd Feb 20257:00 amRNSTotal Voting Rights
27th Jan 20253:59 pmRNSNotice of AGM
14th Jan 20257:00 amRNSRoke Contract Award
2nd Jan 202511:01 amRNSTotal Voting Rights
19th Dec 20247:00 amRNSAdditional Listing
18th Dec 20241:30 pmRNSDirector/PDMR Shareholding
18th Dec 20241:30 pmRNSDirector/PDMR Shareholding
18th Dec 20241:30 pmRNSDirector/PDMR Shareholding
18th Dec 20241:30 pmRNSDirector/PDMR Shareholding
18th Dec 20241:30 pmRNSDirector/PDMR Shareholding
18th Dec 202410:30 amRNSDirector/PDMR Shareholding
18th Dec 202410:30 amRNSDirector/PDMR Shareholding
18th Dec 202410:30 amRNSDirector/PDMR Shareholding
18th Dec 202410:30 amRNSDirector/PDMR Shareholding
18th Dec 202410:30 amRNSDirector/PDMR Shareholding
18th Dec 202410:30 amRNSDirector/PDMR Shareholding
18th Dec 20247:00 amRNSBlock listing Interim Review
17th Dec 202412:49 pmRNSDirector/PDMR Shareholding
17th Dec 20247:00 amRNSResults for the year ended 31 October 2024
5th Dec 20247:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.